Cure Alzheimer's Fund

Art Blocks to Host Auction of Generative Art to Benefit Cure Alzheimer's Fund

Retrieved on: 
Friday, October 20, 2023
Fund, Alzheimer's disease, Genetics, Fourth Arts Block, Sale, Regen, Disease, ALS Association, Cure Alzheimer's Fund, ALS, Degenerative disease, Research, Probability, Life, Pharmaceutical industry

Proceeds from the auction of 1,000 NFTs (200 per day) will be donated to Cure Alzheimer's Fund.

Key Points: 
  • Proceeds from the auction of 1,000 NFTs (200 per day) will be donated to Cure Alzheimer's Fund.
  • The upcoming auction supports the work of Cure Alzheimer's Fund, a non-profit organization dedicated to funding research with the highest probability of preventing, slowing or reversing Alzheimer's disease.
  • A week-long charitable event featuring daily auctions of 200 works by five leading generative artists, minted on Art Blocks.
  • Art Blocks , a platform dedicated to bringing compelling works of contemporary generative art to life.

CURE ALZHEIMER'S FUND LAUDS ARMOUR, APPOINTS SMITH AS CEO

Retrieved on: 
Monday, October 2, 2023
Newton, Berkman Klein Center for Internet & Society, Duke University, Partnership, Professional, Pathology, Charity Navigator, Research, Harvard Law School, Bangladesh Technical Education Board, McKinsey & Company, Massachusetts Supreme Judicial Court, Cure Alzheimer's Fund, Science, Retirement, Patient, Berkman, Chairperson, Growth, Fund, Death, Disease, Management, Pharmaceutical industry, Alzheimer's disease

"I am honored by the trust placed in me by the Board of Directors of Cure Alzheimer's Fund," Ms. Smith said.

Key Points: 
  • "I am honored by the trust placed in me by the Board of Directors of Cure Alzheimer's Fund," Ms. Smith said.
  • Since its founding in 2004, Cure Alzheimer's Fund has provided grants to more than 750 of the world's leading researchers and contributed more than $175 million to research.
  • Cure Alzheimer's Fund has received a 4-star rating for 12 consecutive years from Charity Navigator.
  • With 100% of funds raised going to support research, Cure Alzheimer's Fund has been able to provide grants to many of the best scientific minds in the field of Alzheimer's research.

Cure Alzheimer's Fund Announces 18th Straight Year of Record Results

Retrieved on: 
Thursday, June 22, 2023
Cure Alzheimer's Fund, Alzheimer's disease, Fund, Research, Investment, Trustee, Annual report, Disease, Cryptocurrency, Pharmaceutical industry

WELLESLEY HILLS, Mass., June 22, 2023 /PRNewswire/ -- Cure Alzheimer's Fund has announced that 2022 marks its 18th consecutive year of record results for contributions raised to fund research into Alzheimer's disease.

Key Points: 
  • WELLESLEY HILLS, Mass., June 22, 2023 /PRNewswire/ -- Cure Alzheimer's Fund has announced that 2022 marks its 18th consecutive year of record results for contributions raised to fund research into Alzheimer's disease.
  • "2022 was the strongest year in Cure Alzheimer's Fund history," said Tim Armour, CEO of Cure Alzheimer's Fund.
  • "The generosity of so many has enabled Cure Alzheimer's Fund to invest in research that contributes to significant advances in our understanding of the disease.
  • Cure Alzheimer's Fund is a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease.

Cure Alzheimer's Fund Receives $8,400 From Quincy Firefighters

Retrieved on: 
Thursday, May 25, 2023
Organic, DevOps, Hockey, International Association, Research, Cure Alzheimer's Fund, Alzheimer's disease, Johnstone Olindi, Fund, IAFF, Disease, Firefighter

WELLESLEY HILLS, Mass., May 25, 2023 /PRNewswire/ -- The International Association of Firefighters (IAFF) Local 792 in Quincy, Massachusetts, has presented Cure Alzheimer's Fund with a contribution of $8,400 to Alzheimer's disease research. Lt. Ralph Blight and Firefighter Tom Bowes presented the donation which resulted from a hockey event and a local bowling fundraiser in Quincy.

Key Points: 
  • WELLESLEY HILLS, Mass., May 25, 2023 /PRNewswire/ -- The International Association of Firefighters (IAFF) Local 792 in Quincy, Massachusetts, has presented Cure Alzheimer's Fund with a contribution of $8,400 to Alzheimer's disease research.
  • "Their generosity and spirit are extraordinary, and we are so grateful to the Quincy Firefighters for their heroic efforts and dedication to the community."
  • This was the 6th year that IAFF Local 792 held a fundraiser at Olindy's bowling in Quincy, with all proceeds benefiting Cure Alzheimer's Fund.
  • Cure Alzheimer's Fund is a non-profit dedicated to funding the most promising research to prevent, slow, or reverse Alzheimer's disease.

CURE ALZHEIMER'S FUND RECEIVES CORPORATE DONATION FROM ORVEON GLOBAL

Retrieved on: 
Monday, March 13, 2023
Disease, Research, Alzheimer's disease, Pathology, Woman, Centre for Infectious Disease Research in Zambia, Cure Alzheimer's Fund, Pharmaceutical industry

WELLESLEY, Mass., March 13, 2023 /PRNewswire/ -- Cure Alzheimer's Fund, a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease, announced today it has received more than $136,000 from Orveon Global. Launched in December 2021, Orveon is a standalone collective of premium and prestige beauty brands, including bareMinerals, BUXOM and Laura Mercier. As part of its mission to drive positive change, Orveon is committed to supporting causes and nonprofits that align with this goal.

Key Points: 
  • Launched in December 2021, Orveon is a standalone collective of premium and prestige beauty brands, including bareMinerals, BUXOM and Laura Mercier.
  • As part of its mission to drive positive change, Orveon is committed to supporting causes and nonprofits that align with this goal.
  • "Alzheimer's disease is indiscriminate in whom it affects, and it spares neither the patient nor their loved ones," said Tim Armour, President and CEO of Cure Alzheimer's Fund.
  • "At Orveon, one of our core values is benevolent activism, which means we focus on empowering impactful innovation, from sustainability in beauty to causes that drive real change," said Robert Rigby-Hall, Chief People Officer of Orveon Global.

CURE ALZHEIMER'S FUND APPOINTS DRS. JOHN S. LAZO AND PATRICK C. MAY TO RESEARCH STRATEGY COUNCIL

Retrieved on: 
Tuesday, February 14, 2023
University, Biotechnology, Charity Navigator, Cure Alzheimer's Fund, Therapy, Yale University, Ageing, Pharmacology, RSC, Johnson & Johnson, Patient, National Academy of Agricultural Research Management, United States Air Force Scientific Advisory Board, Research, Fund, Pathology, Eli Lilly, Research fellow, Eli Lilly and Company, Chair, Drug discovery, Book, Pharmaceutical industry, Alzheimer's disease, DRS

WELLESLEY, Mass., Feb. 14, 2023 /PRNewswire/ -- Cure Alzheimer's Fund, a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease, is pleased to announce the appointment of Drs. John S. Lazo and Patrick C. May to its Research Strategy Council.

Key Points: 
  • John S. Lazo and Patrick C. May to its Research Strategy Council.
  • The Cure Alzheimer's Fund Research Strategy Council (RSC) is composed of six extraordinary individuals with a wide range of relevant expertise.
  • The RSC works closely with the Cure Alzheimer's Fund Research Leadership Group and its Chair, Dr. Rudy Tanzi, and reports to the Board of Directors regarding its recommendations.
  • With 100% of funds raised going to support research, Cure Alzheimer's Fund has been able to provide grants to many of the best scientific minds in the field of Alzheimer's research.

CURE ALZHEIMER'S FUND HONORS THE SCIENTISTS WORKING TO FIND A CURE

Retrieved on: 
Thursday, December 8, 2022
Caregiver, Alzheimer's disease, Fund, Charity Navigator, Disease, Baby boomers, Cure Alzheimer's Fund, Pathology, Research, Pharmaceutical industry

WELLESLEY, Mass., Dec. 8, 2022 /PRNewswire/ -- Cure Alzheimer's Fund, a non-profit dedicated to funding the most promising research to prevent, slow, or reverse Alzheimer's disease, honored the exceptional scientists who have been working so diligently to find a cure for the disease with a special tribute publication.

Key Points: 
  • "We proudly fund their bold ideas, support their creative thinking, and encourage them to collaborate, because that is what it will take to cure Alzheimer's disease."
  • Since its founding, Cure Alzheimer's Fund has provided grants to 249 of the world's leading researchers who have dedicated their lives to finding solutions for the disease.
  • Cure Alzheimer's Fund is a non-profit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease.
  • Cure Alzheimer's Fund has received a 4-star rating for more than 10 consecutive years from Charity Navigator.

CURE ALZHEIMER'S FUND RECEIVES $30,000 GRANT FROM GREATER TOLEDO COMMUNITY FOUNDATION

Retrieved on: 
Thursday, December 1, 2022
Pathology, Alzheimer's disease, Toledo metropolitan area, Partnership, Caregiver, Charity Navigator, Disease, Drug development, Fund, Cure Alzheimer's Fund, Research, Quality of life, Baby boomers, Pharmaceutical industry

WELLESLEY, Mass., Dec. 1, 2022 /PRNewswire/ -- Cure Alzheimer's Fund, a non-profit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease, announced today that it has received a $30,000 grant from the Robert A. Stranahan, Jr. Charitable Advised Fund of the Greater Toledo Community Foundation. This most recent grant continues important philanthropic support from the Robert A. Stranahan, Jr. Charitable Advised Fund as the fund has donated $185,000 to CureAlz since making its first grant in 2016. 

Key Points: 
  • WELLESLEY, Mass., Dec. 1, 2022 /PRNewswire/ -- Cure Alzheimer's Fund , a non-profit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease, announced today that it has received a $30,000 grant from the Robert A. Stranahan, Jr. Charitable Advised Fund of the Greater Toledo Community Foundation .
  • "We are especially encouraged by the collaborative nature of the work supported by Cure Alzheimer's Fund (CureAlz) and their success at leveraging additional funds to further research into understanding Alzheimer's disease," said Keith Burwell, President of Greater Toledo Community Foundation.
  • Gratefully, the Greater Toledo Community Foundation also recognizes the importance of focusing on foundational and translational research.
  • Greater Toledo Community Foundation is a public charitable organization created by citizens of our community to enrich the quality of life for individuals and families in our area.

Gene Mutation May Explain Brain Cell Plaque Buildup in Alzheimer's Disease

Retrieved on: 
Wednesday, November 30, 2022
Doctor of Philosophy, Cure Alzheimer's Fund, National Institutes of Health, Cell, NYU Langone Health, Mutation, Gene, Hasel, Glaucoma, New York University Grossman School of Medicine, DNA, Bacteria, Brain, Enzyme, Alzheimer's Research UK, INPP5D, Physiology, Alzheimer's Association, Inflammation, Rockefeller Neuroscience Institute, Microglia, Parkinson's disease, NYU, Plaque, Icahn School of Medicine at Mount Sinai, Neurodegeneration, Multiple sclerosis, Journal, Mouse, Ophthalmology, Virus, Monroe Dunaway Anderson, Huntington's disease, Research, Human, Mount Sinai, BA, Vaccine, Pharmaceutical industry, Medical imaging, Antibiotics, Neuroscience, Dementia, MD, Shelly Liddelow, Alzheimer's disease, Medicine

The buildup of such clumps, also called plaque, sets off an immune response that can kill brain cells and may lead to the dementia associated with Alzheimer's disease.

Key Points: 
  • The buildup of such clumps, also called plaque, sets off an immune response that can kill brain cells and may lead to the dementia associated with Alzheimer's disease.
  • The new findings may offer a potential new target for therapies that directly affect the gene mutation, according to the study authors.
  • Notably, this cluster is known to produce molecules that trigger inflammation in Parkinson's disease, Huntington's disease, and various forms of dementia.
  • They compared these findings to previous research in humans with Alzheimer's disease, observing the same genetic changes in the gene cluster linked to plaque.

CURE ALZHEIMER'S FUND REACHES $150 MILLION IN RESEARCH GRANTS

Retrieved on: 
Thursday, September 22, 2022
Fund, Charity Navigator, FDA, APOE, Genome project, Library, Cure Alzheimer's Fund, CEO, Science, Board, Research, Genome, Disease, Pharmaceutical industry, Alzheimer's disease

WELLESLEY, Mass., Sept. 22, 2022 /PRNewswire/ -- Cure Alzheimer's Fund, a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease, announced today that it has reached an important milestone—awarding more than $150 million in research grants to many of the leading scientists throughout the world investigating the disease.

Key Points: 
  • Cure Alzheimer's Fund is a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease.
  • Since its founding in 2004, Cure Alzheimer's Fund has contributed more than $150 million to research, and its funded initiatives have been responsible for many key breakthroughs.
  • Cure Alzheimer's Fund has received a 4-star rating for more than 10 consecutive years from Charity Navigator.
  • With 100% of funds raised going to support research, Cure Alzheimer's Fund has been able to provide grants to many of the best scientific minds in the field of Alzheimer's research.